brbr-202511140001772016false00017720162025-11-142025-11-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 14, 2025
BellRing Brands, Inc.
(Exact name of registrant as specified in its charter) | | | | | | | | | | | |
| Delaware | 001-39093 | 87-3296749 |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
|
|
|
|
| 2503 S. Hanley Road | St. Louis | Missouri | 63144 |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (314) 644-7600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | |
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.01 par value per share | BRBR | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) Newly Elected Directors.
On November 12, 2025, the Board of Directors (the “Board”) of the Company approved an increase in the size of the Board from seven (7) to eight (8) members, effective January 1, 2026. In connection with this expansion, the Board appointed David I. Finkelstein to fill the newly created seat, also effective January 1, 2026. Mr. Finkelstein’s initial term will expire at the Company’s Annual Meeting of Shareholders in 2026.
The Board has determined that Mr. Finkelstein satisfies the requirements for independence and financial literacy under the listing standards of the New York Stock Exchange and the Company’s Corporate Governance Guidelines. On November 12, 2025, the Board also appointed Mr. Finkelstein to serve on the Audit Committee of the Board, effective January 1, 2026.
Mr. Finkelstein was appointed to the Board after a thorough review of his qualifications by the Corporate Governance and Compensation Committee of the Board. Mr. Finkelstein will receive compensation as a non-employee director in accordance with the Company’s non-employee director compensation program described in the Company’s Annual Proxy Statement filed with the Securities and Exchange Commission on December 17, 2024. There is no arrangement or understanding between Mr. Finkelstein and any other persons pursuant to which he was appointed as a director, and there are no transactions in which he has an interest requiring disclosure under Item 404(a) of Regulation S-K. The Company expects to enter into its standard form of indemnification agreement with Mr. Finkelstein, the form of which was previously filed as Exhibit 10.10 to the Company’s Form 10-K filed on November 19, 2024.
Item 7.01. Regulation FD Disclosure.
The Company issued a press release on November 14, 2025 announcing the announcing the expansion of the Board and the appointment of Mr. Finkelstein to the Board, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.
The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall such information or exhibit be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| | | | | |
| Exhibit No. | Description |
| |
| 99.1 | |
| 104 | Cover Page Interactive Data File (the cover page iXBRL tags are embedded within the Inline XBRL document) |
| |
| |
| |
| |
| |
| |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | |
| Date: November 14, 2025 | BellRing Brands, Inc. |
| (Registrant) |
|
|
|
| By: | /s/ Craig L. Rosenthal |
| Name: | Craig L. Rosenthal |
| Title: | Chief Legal Officer and Secretary |